![CUSP Supports FDA Data Improvement Plan](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_2560,h_1707/https://centerforuspolicy.org/wp-content/uploads/2024/01/AdobeStock_184811519EDIT-3-scaled.jpg)
CUSP Supports FDA Data Improvement Plan
CUSP sends letter supporting FDA’s plan to improve substance misuse data collection, highlighting the crucial role of the RADARS System in addressing substance misuse.
![The Role of Compliance Plans in Opioid Prescribing](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_1127,h_751/https://centerforuspolicy.org/wp-content/uploads/2024/01/Picture1.jpg)
The Role of Compliance Plans in Opioid Prescribing
Medpage Today discusses opioid prescribing challenges, emphasizing legal fears and advocating for compliance plans with potential patient benefits.
![Special Edition of JOM Focuses on Opioid Law and Policy](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_727,h_485/https://centerforuspolicy.org/wp-content/uploads/2023/11/Picture1.png)
Special Edition of JOM Focuses on Opioid Law and Policy
The Journal of Opioid Management has released a special edition on pain management and opioid misuse, titled "Legal, Legislative, and Regulatory Approaches to Reducing Opioid Use Disorder and Opioid-Involved Poisonings."
![FDA Denies Citizen Petition to Protect Patients](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_2560,h_1707/https://centerforuspolicy.org/wp-content/uploads/2023/08/AdobeStock_414656141_Editorial_Use_Only-scaled.jpeg)
FDA Denies Citizen Petition to Protect Patients
Inside Health Policy covers FDA’s denial of CUSP’s Citizen Petition urging the FDA to recall a software that influences the prescribing of controlled medications.
![FDA Denial of Petition to Protect Marginalized Patients](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_1214,h_911/https://centerforuspolicy.org/wp-content/uploads/2023/08/AdobeStock_521699068_FDA_Editorial_Use_Only_edited-1.jpg)
FDA Denial of Petition to Protect Marginalized Patients
The FDA has denied CUSP’s Citizen Petition aimed at protecting patients from being deprived of the prescription drugs they need.
![FDA Should Recall Software to Protect Patients](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_2560,h_1707/https://centerforuspolicy.org/wp-content/uploads/2023/07/AdobeStock_315153214-scaled.jpeg)
FDA Should Recall Software to Protect Patients
Axios reports on CUSP’s citizen petition asking the FDA to recall a widely used clinical decision support software.
![Health Policy Advocates Oppose Federal Opioid Treatment Bill](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_2560,h_1707/https://centerforuspolicy.org/wp-content/uploads/2023/05/AdobeStock_281116336-scaled.jpeg)
Health Policy Advocates Oppose Federal Opioid Treatment Bill
Health policy advocates oppose federal opioid treatment bill to "authorize" methadone dispensing in pharmacies.
![Health Policy Advocates Petition FDA to Recall Software](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_558,h_372/https://centerforuspolicy.org/wp-content/uploads/2023/08/IMG_0112.jpeg)
Health Policy Advocates Petition FDA to Recall Software
Inside Health Policy reports on CUSP’s Citizen Petition urging the FDA to initiate a recall of a widely-used clinical decision support software.
![Woman speaking with health care provider](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_2550,h_1700/https://centerforuspolicy.org/wp-content/uploads/2023/04/FDA-Cit-Pet-2.jpg)
CUSP Files FDA Citizen Petition to Protect Patients
Petition seeks to recall software that unfairly limits access to prescription drugs.
![Barnes to Speak at 2023 Rx Summit](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_2560,h_1707/https://centerforuspolicy.org/wp-content/uploads/2023/02/Barnes-to-Speak-at-2023-Rx-Summit-scaled.jpeg)
Barnes to Speak at 2023 Rx Summit
Michael C. Barnes, Esq., Principal Attorney at Sequel Legal, will speak and moderate in-person at the 2023 Rx Drug Abuse & Heroin Summit in Atlanta, Georgia.